The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has $11.97 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $11.97 B | 9.4% |
2023-12-31 | $10.94 B | 17.61% |
2022-12-31 | $9.30 B | 15.78% |
2021-12-31 | $8.03 B | -24.51% |
2020-12-31 | $10.64 B | 19.48% |
2019-12-31 | $8.91 B | -69.59% |
2018-12-31 | $29.30 B | -29.69% |
2017-12-31 | $41.67 B | 9.43% |
2016-12-31 | $38.08 B | 21.36% |
2015-12-31 | $31.38 B | 16.12% |
2014-12-31 | $27.02 B | 39.3% |
2013-12-31 | $19.40 B | -19.37% |
2012-12-31 | $24.06 B | 16.57% |
2011-12-31 | $20.64 B | 18.48% |
2010-12-31 | $17.42 B | 29.61% |
2009-12-31 | $13.44 B | 40.72% |
2008-12-31 | $9.55 B | 33.58% |
2007-12-31 | $7.15 B | 13.92% |
2006-12-31 | $6.27 B | 19.45% |
2005-12-31 | $5.25 B | -9.52% |
2004-12-31 | $5.80 B | 13.37% |
2003-12-31 | $5.12 B | 9.84% |
2002-12-31 | $4.66 B | 75.19% |
2001-12-31 | $2.66 B | 31.27% |
2000-12-31 | $2.02 B | 52.15% |
1999-12-31 | $1.33 B | 562.85% |
1998-12-31 | $0.20 B | -15.89% |
1997-12-31 | $0.23 B | 41.23% |
1996-12-31 | $0.16 B |